Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists
- PMID: 33231613
- DOI: 10.1093/cvr/cvaa334
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists
Comment on
-
The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.Cardiovasc Res. 2021 Jul 27;117(9):2108-2124. doi: 10.1093/cvr/cvaa256. Cardiovasc Res. 2021. PMID: 32871009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
